Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
The current price of CTKB is $4.09 USD — it has increased by +3.02% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cytek BioSciences stocks are traded under the ticker CTKB.
Is Cytek BioSciences stock price growing?▼
CTKB stock has risen by +8.49% compared to the previous week, the month change is a -8.3% fall, over the last year Cytek BioSciences has showed a +59.14% increase.
What is Cytek BioSciences market cap?▼
Today Cytek BioSciences has the market capitalization of 522.97M
When is the next Cytek BioSciences earnings date?▼
Cytek BioSciences is going to release the next earnings report on August 12, 2026.
What were Cytek BioSciences earnings last quarter?▼
CTKB earnings for the last quarter are -0.15 USD per share, whereas the estimation was -0.09 USD resulting in a -62.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytek BioSciences revenue for the last year?▼
Cytek BioSciences revenue for the last year amounts to 400.91M USD.
What is Cytek BioSciences net income for the last year?▼
CTKB net income for the last year is -12.04M USD.
How many employees does Cytek BioSciences have?▼
As of May 27, 2026, the company has 663 employees.
In which sector is Cytek BioSciences located?▼
Cytek BioSciences operates in the Health & Wellness sector.
When did Cytek BioSciences complete a stock split?▼
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?▼
Cytek BioSciences is headquartered in Fremont, United States.